ClinicalTrials.gov
public full text
Public Domain
A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia
The main purpose of this study is to evaluate the efficacy and safety of the study drug known as evacetrapib in Japanese participants with primary hypercholesterolemia. The double blind treatment period will last for 12 weeks and the open-label extension period will last for an additional 40 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia#829802
- An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia#918409
- Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia#915823
- Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes#1182612
- Hemşirelikte lisans programını değerlendirme ölçeği (HLPDÖ): Geliştirilmesi, geçerliği, güvenirliği#954644
Record · ID 1183861
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive